Development and Clinical Validation of an Ultra-Fast CAR-T Manufacturing Platform Enabling Production of CAR-T Cells in Less Than 1 Day

被引：2
|
作者：
Stadel, Ryan [1 ]
Idippily, Nethrie [1 ]
Giraudo, Maria Florencia [1 ]
Caimi, Paolo [2 ]
Van Besien, Koen
Martin, James [3 ]
Wu, John [4 ]
Deng, Changchun [5 ]
Wald, David [1 ,6 ]
机构：
[1] Kure Ai, Cleveland, OH USA
[2] Taussig Canc Inst, Cleveland Clin, Dept Hematol & Med Oncol, Cleveland, OH USA
[3] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA
[4] Promab, Richmond, CA USA
[5] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[6] Case Western Reserve Univ, Cleveland, OH USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188214
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] GvHD: Non-clinical findings in the development of CAR-T cells projects
    Di Gallo, G.
    Magistrelli, M.
    Pennella, G.
    Mancini, L.
    Russo, M.
    Giannotti, E.
    Bernardi, C. I.
    TOXICOLOGY LETTERS, 2019, 314 : S72 - S72
  • [32] CAR-T CELLS MANUFACTURING AT ADVANCED BIOMANUFACTURING FACILITY JACKSONVILLE FLORIDA
    Oancea, A.
    Shao, Q.
    Lin, S.
    Manadilo, F.
    Ecker, K.
    Yin, N.
    Crist, A.
    Qin, H.
    CYTOTHERAPY, 2024, 26 (06) : E26 - E26
  • [33] A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
    Bajgain, Pradip
    Mucharla, Roopa
    Anurathapan, Usanarat
    Lapteva, Natalia
    Leen, Ann M.
    Heslop, Helen E.
    Rooney, Cliona M.
    Vera, Juan F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S194 - S195
  • [34] Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
    Golubovskaya, Vita
    Zhou, Hua
    Li, Feng
    Berahovich, Robert
    Sun, Jinying
    Valentine, Michael
    Xu, Shirley
    Harto, Hizkia
    Sienkiewicz, John
    Huang, Yanwei
    Wu, Lijun
    BIOMEDICINES, 2021, 9 (10)
  • [35] IMPROVEMENT CAR-T CELL THERAPY WITH ULTRA-FAST PROTOCOL AND IL-15 MEMBRANE BOUND ADDITION
    Abdo, L.
    Barros, L.
    Viegas, M.
    Marques, L.
    Ferreira, P.
    Aragao, E.
    Hadju, K.
    Ribeiro, L.
    Chicaybam, L.
    Bonamino, M.
    CYTOTHERAPY, 2022, 24 (10) : S1 - S1
  • [36] Reshape of CAR-T cells by overexpression of TCF-1
    Yao, H.
    Wang, L.
    Ding, Y.
    Wang, S.
    Chen, Q.
    Han, H.
    Lin, M.
    Sauer, T.
    Jiang, G.
    Neuber, B.
    Schibert, M. -L.
    Eckstein, V.
    Mueller-Tidow, C.
    Schmitt, A.
    Schmitt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 302 - 302
  • [37] THE MRD STATUS ON DAY 7 AND CD4 COUNT AT 1 MONTH AFTER CAR-T THERAPY ARE PROGNOSTIC INDICATORS IN CAR-T TREATMENTS
    Gao, Li
    Lu, Jun
    Cheng, Shengqin
    Wang, Yuxuan
    Xiao, Peifang
    He, Hailong
    Wang, Yi
    Li, Jie
    Hu, Shaoyan
    BONE MARROW TRANSPLANTATION, 2024, 59 : 14 - 14
  • [38] Modular Semi-Automated Clinical Scale Manufacturing of CAR-T Cells for Cancer Immunotherapy
    Desai, Kunjan
    Somasagara, Ranganatha
    Ravinder, Namritha
    MOLECULAR THERAPY, 2023, 31 (04) : 379 - 379
  • [39] A scalable method for the production of exosomes derived from CAR-T cells
    Heredia, P.
    Pavlovic, K.
    Perucha, B.
    Cortijo, M.
    Ronco, V.
    Martin, F.
    Herrera, I. C.
    Carmona, M. D.
    Marchal, J. A.
    Benabdellah, K.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A134 - A134
  • [40] Clinical development of CAR-T cells - challenges and opportunities in translating innovative treatment concepts
    Hartmann, J.
    Schuessler-Lenz, M.
    Bondanza, A.
    Buchholz, C. J.
    HUMAN GENE THERAPY, 2017, 28 (12) : A34 - A34
12345